If I may make a suggestion, I think it would help to be more explicit about this. I know several founders of biotech companies treating age related diseases lik

If I may make a suggestion, I think it would help to be more explicit about this. I know several founders of biotech companies treating age related diseases like cancer, Alzheimer's, etc who don't apply to YC bc they think YC only wants pills to extend life / parabiosis etc. "longevity" means very different things (and has different connotations) in the "tech" startup world vs the biopharma startup world. I know a lot of tech VCs are wary of the word "biotech" and related terms bc they got burned a decade ago, but bread and butter biotech is a totally different world the last few years and has been one of the most rewarding areas for startups and investors. The tech funds that lean into traditional biopharma are getting into a lot of great deals while those who try to stay at arms length from traditional biopharma are missing the best opportunities